Abstract
Objective:
Osteogenesis imperfecta (OI) is a rare genetic disorder characterized by defects in type I collagen that can pose serious complications during pregnancy. The aim was to evaluate maternal and fetal outcomes in pregnant women with OI.
Study Design:
This was a retrospective cohort study, using the Healthcare Cost and Utilization Project Nationwide Inpatient Sample. We examined the records of pregnant women with OI during the period 2003 to 2011. We evaluated antenatal complications and method of delivery among 295 women with OI, using unconditional logistic regression.
Results:
Of the total 7 287 994 births in our cohort, we encountered 295 deliveries among women with OI. The prevalence was 4 per 1 00 000 deliveries per year over the study period. Births to women with OI were more likely to be complicated by antepartum hemorrhage (odds ratio (OR) 2.01, 95% confidence interval (CI) 1.04 to 3.91), placenta abruption (OR 2.50, 95% CI 1.24 to 5.03), intrauterine growth restriction and small-for-gestational-age infants (OR 2.42, 95% CI 1.42 to 4.14), congenital malformation (OR 7.33, 95% CI 4.20 to 12.78) and preterm birth (OR 2.24, 95% CI 1.63 to 3.06). Seventy-five percent of women with OI delivered by cesarean section, and they had an increased rate of tubal sterilization at delivery (OR 1.67, 95% CI 1.18 to 2.36). No differences in rates of stress fracture and maternal death were found.
Conclusion:
These findings suggest that there are increased risks to both mother and fetus in pregnancies complicated by OI.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
van Dijk FS, Cobben JM, Kariminejad A, Maugeri A, Nikkels PG, van Rijn RR et al. Osteogenesis imperfecta: a review with clinical examples. Mol Syndromol 2011; 2 (1): 1–20.
Orioli IM, Castilla EE, Barbosa-Neto JG . The birth prevalence rates for the skeletal dysplasias. J Med Genet 1986; 23 (4): 328–332.
Van Dijk FS, Pals G, Van Rijn RR, Nikkels PGJ, Cobben JM . Classification of osteogenesis imperfecta revisited. Eur J Med Genet 2010; 53 (1): 1–5.
Chen CP, Lin SP, Su YN, Huang JP, Chern SR, Su JW et al. Uncomplicated vaginal delivery in two consecutive pregnancies carried to term in a woman with osteogenesis imperfecta type I and bisphosphonate treatment before conception. Taiwan J Obstet Gynecol 2012; 51 (2): 305–307.
Feng ZY, Chen Q, Shi CY, Wen HW, Ma K, Yang HX . A type IV osteogenesis imperfecta family and pregnancy: a case report and literature review. Chin Med J (Engl) 2012; 125 (7): 1358–1360.
Key TC, Horger EO 3rd . Osteogenesis imperfecta as a complication of pregnancy. Obstet Gynecol 1978; 51: 67–71.
Sharma A, George L, Erskin K . Osteogenesis imperfecta in pregnancy: two case reports and review of literature. Obstet Gynecol Surv 2001; 56 (9): 563–566.
Yimgang DP, Shapiro JR . Pregnancy outcomes in women with osteogenesis imperfecta. J Matern Fetal Neonatal Med 2016; 29 (14): 2358–2362.
Young BK, Gorstein F . Maternal osteogenesis imperfecta. Obstet Gynecol 1968; 31 (4): 461–470.
Krishnamoorthy U, Vausse S, Donnai P . Management of pregnancy complicated by maternal osteogenesis imperfecta. Report of a case with uterine rupture. J Obstet Gynaecol 2002; 22 (3): 316.
Litos M, Brown . Osteogenesis imperfecta and pregnancy. Eur J Obstet Gynecol Reprod Biol 2008; 136 (1):126–127.
Vitale MG, Matsumoto H, Kessler MW, Hoffmann W, Roye DP Jr . Osteogenesis imperfecta: determining the demographics and the predictors of death from an inpatient population. J Pediatr Orthop 2007; 27 (2): 228–232.
Hathaway WE, Solomons CC, Ott JE . Platelet function and pyrophosphates in osteogenesis imperfecta. Blood 1972; 39 (4): 500–509.
Chan B, Zacharin M . Maternal and infant outcome after pamidronate treatment of polyostotic fibrous dysplasia and osteogenesis imperfecta before conception: a report of four cases. J Clin Endocrinol Metab 2006; 91 (6): 2017–2020.
Krakow D. Osteogenesis Imperfecta: A Translational Approach to Brittle Bone Disease, 1st edn. Shapiro JR, Byers P, Florieux F, Sponseller P (eds). Elsevier Inc.: London, UK, 2013.
Cozzolino M, Maggio L, Perelli F, Coccia ME . Ultrasonographic early diagnosis of osteogenesis imperfecta type I: implications for pre and post-natal therapy. Arch Gynecol Obstet 2016; 294 (1): 215–216.
Gotherstrom C, Westgren M, Shaw SW, Astrom E, Biswas A, Byers PH et al. Pre- and postnatal transplantation of fetal mesenchymal stem cells in osteogenesis imperfecta: a two-center experience. Stem Cells Transl Med 2014; 3 (2): 255–264.
Cubert R, Cheng EY, Mack S, Pepin MG, Byers PH . Osteogenesis imperfecta: mode of delivery and neonatal outcome. Obstet Gynecol 2001; 97 (1): 66–69.
Bellur S, Jain M, Cuthbertson D, Krakow D, Shapiro JR, Steiner RD et al. Cesarean delivery is not associated with decreased at-birth fracture rates in osteogenesis imperfecta. Genet Med 2015; 18 (6): 570–576.
Osteogenesis Imperfecta Foundation. Available at http://www.oif.org/site/PageServer?pagename=Pregnancy. Accessed 5 February 2016.
Smith R, Phillips AJ . Osteoporosis during pregnancy and its management. Scand J Rheumatol Suppl 1998; 107: 66–67.
Vogel TM, Ratner EF, Thomas RC Jr, Chitkara U . Pregnancy complicated by severe osteogenesis imperfecta: a report of two cases. Anesth Analg 2002; 94 (5): 1315–1317, (table of contents).
Rauch F, Glorieux FH . Osteogenesis imperfecta. Lancet 2004; 363 (9418): 1377–1385.
Cozzolino M, Perelli F, Maggio L, Coccia ME, Quaranta M, Gizzo S et al. Management of osteogenesis imperfecta type I in pregnancy; a review of literature applied to clinical practice. Arch Gynecol Obstet 2016; 293 (6): 1153–1159.
Carlson JW, Harlass FE . Management of osteogenesis imperfecta in pregnancy. A case report. J Reprod Med 1993; 38 (3): 228–232.
Christodoulou S, Freemont AJ, McVey R, Vause S . Prospective comparative case study of uterine collagen in a woman with osteogenesis imperfecta type 1 who had previously ruptured her uterus. J Obstet Gynaecol 2007; 27 (7): 738–739.
White NJ, Winearls CG, Smith R . Cardiovascular abnormalities in osteogenesis imperfecta. Am Heart J 1983; 106 (6): 1416–1420.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Dr Tulandi is an advisor for Actavis Inc. The other authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Ruiter-Ligeti, J., Czuzoj-Shulman, N., Spence, A. et al. Pregnancy outcomes in women with osteogenesis imperfecta: a retrospective cohort study. J Perinatol 36, 828–831 (2016). https://doi.org/10.1038/jp.2016.111
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jp.2016.111
This article is cited by
-
Bleeding assessment in a large cohort of patients with Osteogenesis Imperfecta
Orphanet Journal of Rare Diseases (2024)
-
The patient clinical journey and socioeconomic impact of osteogenesis imperfecta: a systematic scoping review
Orphanet Journal of Rare Diseases (2023)
-
Osteogenesis Imperfecta: characterization of fractures during pregnancy and post-partum
Orphanet Journal of Rare Diseases (2022)
-
Outcomes of 42 pregnancies in 14 women with cartilage-hair hypoplasia: a retrospective cohort study
Orphanet Journal of Rare Diseases (2020)
-
Osteogenesis imperfecta and pregnancy: a case report
Journal of Medical Case Reports (2019)